- Home
- NVVE vs VRAX Comparison
NVVE vs VRAX Comparison
Compare NVVE & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVVE | VRAX |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United Kingdom |
| Employees | 12 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NVVE | VRAX |
|---|---|---|
| Price | $0.88 | $0.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | ★ 201.1K | 182.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $892.33 | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.10 | $0.19 |
| 52 Week High | $5.69 | $1.58 |
Technical Indicators
Market Signals| Indicator | NVVE | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 39.56 |
| Support Level | $0.83 | $0.20 |
| Resistance Level | $1.13 | $0.25 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 14.16 | 24.74 |
Price Performance
Historical ComparisonAbout NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.